DLA Piper Sweden
Client SatisfactionDLA Piper Sweden leverages its international network to advise its broad client base on pricing and reimbursement issues. Practice head Fredrika Allard is noted for her specialism in regulation governing the marketing of pharmaceuticals and collaborations between health professionals within the pharma industry, while competition specialist Erik Brändt Öfverholm has deep knowledge of domestic merger control mandates. Jennie Nilsson leads the firm’s digital, data and cyber group, regularly handling GDPR management projects and issues concerning transparency obligations and intra-group data transfers between companies.
Testimonials
Collated independently by Legal 500 research team.
‘The local representatives in Sweden were very pleasant, competent, efficient and delivered all tasks in a timely manner and according to all specs.’
‘I, as team leader from the Nordics, must mention that Fredrika Allard is extremely professional and knowledgeable in the field of pharma. She was always available to discuss, always took the time to re-evaluate if needed and adjusted the work and final product to our specific needs. I couldn't give enough high praise for a job well done so far.’
‘Knowledgeable and accessible.’
Key clients
- Jazz Pharmaceuticals
- Gilead Sciences Sweden AB
- Pfizer
- Ipsen Pharmaceuticals
- ITB-Med AB
- Qbtech AB
- Dynamic Code AB
- Doctrin AB
- HerCare Sweden AB
- Attendo
- Läkemedelsindustriföreningen (Lif)
- Dexcom
- Kartos Therapeutics LLC
- Syneos Health
- ABC Labs
- Karolinska Development
- Imagine Care
- 10xGenomics
- RFSU
- e-Verifikation i Sverige AB
Work highlights
- Advised a US-based biotech company on questions regarding the transfer of human biological samples under new biobank legislation.
- Advised ITB-Med, a Swedish biopharmaceutical company developing specific immunomodulatory biologics for transplantation, autoimmunity, neurodegenerative diseases and gene therapy, on various data protection matters, including issues relating to clinical trials.
- Advised a pharmaceuticals company on reimbursement and administrative procedural law issues in relation to a decision issued by the Swedish Dental and Pharmaceutical Benefits Agency.